ChunLab Inc
CJ Bioscience, Inc. provides microbiome solutions to address unmet medical needs in South Korea and internationally. The company's platform is Ez-Mx, a bioinformatics-based platform for microbiome data analysis. Its product pipeline includes CJRB-101 that is phase I clinical trial for solid tumors; CJRB-201, CJRB-202, and CJRB-203 for inflammatory bowel diseases; CJRB-302 for Parkinson's diseases… Read more
ChunLab Inc (311690) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.086x
Based on the latest financial reports, ChunLab Inc (311690) has a cash flow conversion efficiency ratio of -0.086x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-5.08 Billion) by net assets (₩59.16 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ChunLab Inc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how ChunLab Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ChunLab Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ChunLab Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bangkok Ranch PCL
BK:BR
|
0.065x |
|
Société des Chemins de Fer et Tramways du Var et du Gard
PA:MLCVG
|
N/A |
|
Jakarta Int Hotels & Dev
JK:JIHD
|
0.103x |
|
Hankuk Steel Wire Co. Ltd
KQ:025550
|
-0.012x |
|
Lumi Gruppen AS
OL:LUMI
|
0.171x |
|
New Hoong Fatt Holdings Bhd
KLSE:7060
|
0.088x |
|
Momentum Metropolitan Holdings Ltd
JSE:MTM
|
0.140x |
|
Blue Star Helium Ltd
PINK:BSNLF
|
-0.170x |
Annual Cash Flow Conversion Efficiency for ChunLab Inc (2017–2024)
The table below shows the annual cash flow conversion efficiency of ChunLab Inc from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩77.76 Billion | ₩-27.76 Billion | -0.357x | -2.52% |
| 2023-12-31 | ₩71.50 Billion | ₩-24.90 Billion | -0.348x | +17.63% |
| 2022-12-31 | ₩49.66 Billion | ₩-20.99 Billion | -0.423x | -340.21% |
| 2021-12-31 | ₩87.85 Billion | ₩-8.44 Billion | -0.096x | +58.49% |
| 2020-12-31 | ₩34.48 Billion | ₩-7.98 Billion | -0.231x | -184.85% |
| 2019-12-31 | ₩30.85 Billion | ₩-2.51 Billion | -0.081x | +56.98% |
| 2018-12-31 | ₩10.78 Billion | ₩-2.03 Billion | -0.189x | -58.73% |
| 2017-12-31 | ₩13.16 Billion | ₩-1.57 Billion | -0.119x | -- |